Durvalumab and HAIC-FOLFOX Advance Liver Cancer Treatment
In a groundbreaking advancement for the treatment of hepatocellular carcinoma (HCC), researchers have unveiled promising results from the phase 2 ...
Tag: durvalumab immune checkpoint inhibitor
Phase 1: Ceralasertib, Durvalumab in NSCLC and HNSCC
In a groundbreaking stride towards combating some of the deadliest forms of cancer, researchers have unveiled promising early results from ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!